中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Triterpenoids and alpha-glucosidase inhibitory constituents from Salacia hainanensis

文献类型:期刊论文

作者Yu, Mei-Hua2; Shi, Zheng-Feng2; Yu, Bang-Wei1; Pi, En-Hao2; Wang, He-Yao1; Hou, Ai-Jun2; Lei, Chun2
刊名FITOTERAPIA
出版日期2014-10
卷号98页码:143-148
关键词Salacia hainanensis Lupine Friedelane alpha-Glucosidase
ISSN号0367-326X
DOI10.1016/j.fitote.2014.07.016
文献子类Article
英文摘要Thirteen triterpenoids (1-13), including two new lupane triterpenoids, salacinins A and B (1 and 2), as well as one new friedelane triterpenoid, salacinin C (3), were isolated from the roots and stems of Salacia hainanensis. The structures of new compounds were elucidated by extensive spectroscopic analysis including 1D and 2D NMR, and MS experiments. Compound 1 possesses rare 2,3-secolupane skeleton. Compounds 4,6 and 7 showed inhibitory effects on alpha-glucosidase in vitro. (C) 2014 Elsevier B.V. All rights reserved.
WOS关键词CHUN
资助项目National Natural Science Foundation of China[81222045] ; National Natural Science Foundation of China[21372049] ; Shanghai Municipal Education Commission and Shanghai Education Development Foundation[12SG02]
WOS研究方向Pharmacology & Pharmacy
语种英语
WOS记录号WOS:000343617600020
出版者ELSEVIER SCIENCE BV
源URL[http://119.78.100.183/handle/2S10ELR8/276881]  
专题药理学第三研究室
通讯作者Lei, Chun
作者单位1.Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China
2.Fudan Univ, Sch Pharm, Shanghai 201203, Peoples R China;
推荐引用方式
GB/T 7714
Yu, Mei-Hua,Shi, Zheng-Feng,Yu, Bang-Wei,et al. Triterpenoids and alpha-glucosidase inhibitory constituents from Salacia hainanensis[J]. FITOTERAPIA,2014,98:143-148.
APA Yu, Mei-Hua.,Shi, Zheng-Feng.,Yu, Bang-Wei.,Pi, En-Hao.,Wang, He-Yao.,...&Lei, Chun.(2014).Triterpenoids and alpha-glucosidase inhibitory constituents from Salacia hainanensis.FITOTERAPIA,98,143-148.
MLA Yu, Mei-Hua,et al."Triterpenoids and alpha-glucosidase inhibitory constituents from Salacia hainanensis".FITOTERAPIA 98(2014):143-148.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。